Translate this page into:
Further Evaluation of Therapeutic Efficacy of Dapsone in Cutaneous Leishmaniasis
KK Singh, BB Lal, P Rajvanshi, RD Mukhija, L Mohan
,
Correspondence Address:
K K Singh
Correspondence Address:
K K Singh
| How to cite this article: Singh K K, Lal B B, Rajvanshi P, Mukhija R D, Mohan L. Further Evaluation of Therapeutic Efficacy of Dapsone in Cutaneous Leishmaniasis. Indian J Dermatol Venereol Leprol 1991;57:96-97 |
Copyright: (C)1991 Indian Journal of Dermatology, Venereology, and Leprology
Abstract
Thirty four patients of cutaneous Leishmaniasis had received dapsone as treatment. The dose was approximately 2 mg per kilogram body weight per day. The duration of the treatment ranged from 14 to 63 days with the mean of 31.18 days. Twenty two patients (64.70%) had shown complete healing. Four patients (11.76%) did not show any response. Ulcerative variety (95.23%) responded fully, whereas nodular variety (15.38%) had poor response. No recurrence was seen during a follow up examination of 9 months.
